| Glomerular filtration rate: new age-and gender-specific reference ranges and thresholds for living kidney donation A Fenton, E Montgomery, P Nightingale, AM Peters, N Sheerin, AC Wroe, ... BMC nephrology 19, 1-8, 2018 | 80 | 2018 |
| Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease A Fenton, MD Jesky, CJ Ferro, J Sørensen, MA Karsdal, P Cockwell, ... PLoS One 12 (4), e0175200, 2017 | 73 | 2017 |
| Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study MD Jesky, M Dutton, I Dasgupta, P Yadav, KP Ng, A Fenton, D Kyte, ... PloS one 11 (11), e0165675, 2016 | 68 | 2016 |
| Urinary endotrophin predicts disease progression in patients with chronic kidney disease DGK Rasmussen, A Fenton, M Jesky, C Ferro, P Boor, M Tepel, ... Scientific reports 7 (1), 17328, 2017 | 64 | 2017 |
| Oxidative stress links periodontal inflammation and renal function P Sharma, A Fenton, IHK Dias, B Heaton, CLR Brown, A Sidhu, ... Journal of Clinical Periodontology 48 (3), 357-367, 2021 | 60 | 2021 |
| Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes A Fenton, SW Smith, P Hewins BMC nephrology 19, 1-8, 2018 | 42 | 2018 |
| A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts PF Orlandi, J Huang, M Fukagawa, W Hoy, V Jha, KH Oh, L Sola, ... Kidney international 96 (5), 1217-1233, 2019 | 38 | 2019 |
| Multidisciplinary care improves outcome of patients with stage 5 chronic kidney disease A Fenton, Z Sayar, A Dodds, I Dasgupta Nephron Clinical Practice 115 (4), c283-c288, 2010 | 37 | 2010 |
| Glucocorticoid activation by 11β‐hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross‐sectional study MS Sagmeister, AE Taylor, A Fenton, NA Wall, D Chanouzas, ... Clinical endocrinology 90 (1), 241-249, 2019 | 34 | 2019 |
| Impact of using risk-based stratification on referral of patients with chronic kidney disease from primary care to specialist care in the United Kingdom HK Bhachu, P Cockwell, A Subramanian, NJ Adderley, K Gokhale, ... Kidney international reports 6 (8), 2189-2199, 2021 | 31 | 2021 |
| Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients F Genovese, DGK Rasmussen, MA Karsdal, M Jesky, C Ferro, A Fenton, ... Clinical Kidney Journal 14 (2), 593-601, 2021 | 26 | 2021 |
| The Association of Serum Free Light Chains with Mortality and Progression to end-stage renal disease in chronic kidney disease: systematic review and individual patient data … SDS Fraser, A Fenton, S Harris, A Shardlow, S Liabeuf, ZA Massy, ... Mayo Clinic Proceedings 92 (11), 1671-1681, 2017 | 23 | 2017 |
| Serum tryptase concentration and progression to end‐stage renal disease MD Jesky, SJ Stringer, A Fenton, KP Ng, P Yadav, M Ndumbo, K McCann, ... European journal of clinical investigation 46 (5), 460-474, 2016 | 23 | 2016 |
| A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease S Holm Nielsen, D Guldager Kring Rasmussen, S Brix, A Fenton, M Jesky, ... PLoS One 13 (10), e0204239, 2018 | 17 | 2018 |
| Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease A Fenton, MD Jesky, R Webster, SJ Stringer, P Yadav, I Chapple, ... PloS one 13 (5), e0197043, 2018 | 17 | 2018 |
| Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review HK Bhachu, A Fenton, P Cockwell, O Aiyegbusi, D Kyte, M Calvert BMJ open 12 (1), e055572, 2022 | 16 | 2022 |
| Decreased renal function is associated with incident dementia: An IMRD‐THIN retrospective cohort study in the UK SI Lee, J Cooper, A Fenton, A Subramanian, T Taverner, KM Gokhale, ... Alzheimer's & Dementia 18 (10), 1943-1956, 2022 | 6 | 2022 |
| Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease AHK Karangizi, D Chanouzas, A Fenton, P Moss, P Cockwell, CJ Ferro, ... QJM: An International Journal of Medicine 113 (4), 253-257, 2020 | 6 | 2020 |
| Inequalities in the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database K Phillips, JM Hazlehurst, C Sheppard, S Bellary, W Hanif, MA Karamat, ... Diabetic medicine 41 (1), e15153, 2024 | 5 | 2024 |
| Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study A Fenton, R Chinnadurai, L Gullapudi, P Kampanis, I Dasgupta, J Ritchie, ... PLoS medicine 17 (2), e1003050, 2020 | 5 | 2020 |
